Glenn Wilkins - Wednesday, September 18, 2024 BriaCell Therapeutics Corp. 10:21 AM EST - BriaCell Therapeutics Corp. : Announced U.S. FDA authorization of an Expanded Access Policy (EAP) for metastatic breast cancer (MBC) patients. BriaCell Therapeutics Corp. shares T.BCT are trading up $0.05 at $0.70.